Concepedia

Publication | Closed Access

Vaccine for Prevention of Mild and Moderate-to-Severe Influenza in Children

139

Citations

27

References

2013

Year

Abstract

The QIV was efficacious in preventing influenza in children. (Funded by GlaxoSmithKline Biologicals; ClinicalTrials.gov number, NCT01218308.).

References

YearCitations

Page 1